Precision BioSciences Inc at HC Wainwright Cell Therapy Virtual Conference Transcript
Good afternoon, everyone, and welcome back to H.C. Wainwright's Cell Therapy Virtual Conference. My name is Patrick Trucchio. I'm a senior biotech analyst at H.C. Wainwright. And it's my pleasure to introduce our next speakers: Michael Amoroso, CEO; Derek Jantz, CSO; and Alan List, CMO of Precision BioSciences, a clinical-stage gene editing company developing ARCUS-based ex vivo allogeneic CAR T and in vivo gene editing therapies.
And with that, I'll hand over the presentation to Michael for the introduction.
Thank you, Patrick, and thank you to the Wainwright team for having us. Excited to be with everyone today. Before I hand it over to Dr. List in the moment here, I'll take you through some updates on our allogeneic CAR T programs. Wanted to give a brief background of Precision BioSciences. We say we're a small but mighty group out of Durham. A little less than 200 folks in the Durham, North Carolina area.
We are,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
